A committee of the National Academies of Sciences, Engineering, and Medicine that is developing a framework to evaluate the evidence base for existing clinical practice guidelines for prescribing opioids for acute pain indications will hold a public session on Nov. 13. The study also will identify surgical procedures and health conditions for which new guidelines should be developed and prioritize a research agenda to address the evidence gaps.
The focus of the meeting is for the committee to clarify the scope of the study with its sponsor – the U.S. Food and Drug Administration — and initiate the process of gathering information relevant to the study.
Speakers include:
-
Scott Gottlieb, commissioner, U.S. Food and Drug Administration
-
Christina Mikosz, medical officer, Opioid Overdose Health Systems Team, Division of Unintentional Injury Prevention, Centers for Disease Control and Prevention
-
Judy Staffa, associate director for public health initiatives, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
-
Douglas Throckmorton, deputy director for regulatory programs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
DETAILS:
The public session will be held Tuesday, Nov. 13, from 9:30 to 11:30 a.m. at the National Academies’ Keck Center, 500 Fifth St., N.W., Washington, D.C. Reporters who wish to attend the meeting should register in advance with the Office of News and Public Information; tel. 202-334-2138 or email news@nas.edu. Those who cannot attend in person may register to attend via Zoom. The agenda is available online.